featured
Dupilumab Treatment in Severe Allergic Contact Dermatitis Due to Sesquiterpene Lactones
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Contact Dermatitis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dupilumab Treatment in Two Patients With Severe Allergic Contact Dermatitis Caused by Sesquiterpene Lactones
Contact Derm 2020 Apr 03;[EPub Ahead of Print], IF Ruge, L Skov, C Zachariae, JP ThyssenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.